Navitus Health Solutions’ specialty pharmacy will offer an unbranded biosimilar of Stelara (ustekinumab) that the PBM estimates will save between $112,000 and $336,000 per patient per year compared wi
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
Managed Healthcare Executive